Limited Competition for the Continuation of the Hepatitis B Research Network Clinical Centers (U01)

Funding Agency:
National Institutes of Health

The purpose of this Funding Opportunity Announcement (FOA) is to continue the Hepatitis B Research Network Clinical Centers with a focus on the promotion of translational research on hepatitis B focusing upon elucidating the pathogenesis and natural history and developing means of treatment and control. 

Only one application per institution is allowed. Contact Anastasia Maddox at amm39@duke.edu if you have any questions regarding the internal process for this RFA.

Deadlines:
  • Letter of Intent Due Date(s): November 19, 2016
  • Application Due Date(s): December 19, 2016

RFA-DK-16-512 Expiration Date December 20, 2016

Agency Website

Eligibility Requirements

Only the current HBRN awardees are eligible to apply to this FOA.

Amount Description

The NIDDK intends to commit $7 million dollars in FY 2017 to support the continuation of the Hepatitis B Research Network, as embodied in RFA-DK-14-506RFA-DK-14-510 and this FOA.  It is expected that up to a total of 10 non-competitive Renewal and New meritorious awards will be supported in FY 2017 under these three FOAs.  It is anticipated that up to one award will be made under the current announcement.

Application budgets are not limited but need to reflect the actual needs of the proposed project.

The scope of the proposed project should determine the project period.  The maximum project period is 3 years.

Funding Type

Grant

Eligibility

Faculty

Category

Medical
Medical - Clinical Science
Medical - Translational

External Deadline

December 19, 2016